Global Rufinamide Market Growth (Status and Outlook) 2025-2031

December 2025 | 80 pages | ID: G465F026181EN
LP Information

Abstracts

According to this study, the global Rufinamide market size will reach US$ million by 2031.

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.

United States market for Rufinamide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Rufinamide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Rufinamide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Rufinamide players cover Eisai, Glenmark Pharms, Mylan, West-ward Pharms, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Rufinamide Industry Forecast” looks at past sales and reviews total world Rufinamide sales in 2024, providing a comprehensive analysis by region and market sector of projected Rufinamide sales for 2025 through 2031. With Rufinamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rufinamide industry.

This Insight Report provides a comprehensive analysis of the global Rufinamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rufinamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rufinamide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rufinamide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rufinamide.

This report presents a comprehensive overview, market shares, and growth opportunities of Rufinamide market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Tablets
• Oral suspension

Segmentation by Application:

• Adults
• Pediatric patients

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eisai
• Glenmark Pharms
• Mylan
• West-ward Pharms

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rufinamide Market Size (2020-2031)
  2.1.2 Rufinamide Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Rufinamide by Country/Region (2020, 2024 & 2031)
2.2 Rufinamide Segment by Type
  2.2.1 Tablets
  2.2.2 Oral suspension
2.3 Rufinamide Market Size by Type
  2.3.1 Rufinamide Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Rufinamide Market Size Market Share by Type (2020-2025)
2.4 Rufinamide Segment by Application
  2.4.1 Adults
  2.4.2 Pediatric patients
2.5 Rufinamide Market Size by Application
  2.5.1 Rufinamide Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Rufinamide Market Size Market Share by Application (2020-2025)

3 RUFINAMIDE MARKET SIZE BY PLAYER

3.1 Rufinamide Market Size Market Share by Player
  3.1.1 Global Rufinamide Revenue by Player (2020-2025)
  3.1.2 Global Rufinamide Revenue Market Share by Player (2020-2025)
3.2 Global Rufinamide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RUFINAMIDE BY REGION

4.1 Rufinamide Market Size by Region (2020-2025)
4.2 Global Rufinamide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rufinamide Market Size Growth (2020-2025)
4.4 APAC Rufinamide Market Size Growth (2020-2025)
4.5 Europe Rufinamide Market Size Growth (2020-2025)
4.6 Middle East & Africa Rufinamide Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Rufinamide Market Size by Country (2020-2025)
5.2 Americas Rufinamide Market Size by Type (2020-2025)
5.3 Americas Rufinamide Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rufinamide Market Size by Region (2020-2025)
6.2 APAC Rufinamide Market Size by Type (2020-2025)
6.3 APAC Rufinamide Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rufinamide Market Size by Country (2020-2025)
7.2 Europe Rufinamide Market Size by Type (2020-2025)
7.3 Europe Rufinamide Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rufinamide by Region (2020-2025)
8.2 Middle East & Africa Rufinamide Market Size by Type (2020-2025)
8.3 Middle East & Africa Rufinamide Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RUFINAMIDE MARKET FORECAST

10.1 Global Rufinamide Forecast by Region (2026-2031)
  10.1.1 Global Rufinamide Forecast by Region (2026-2031)
  10.1.2 Americas Rufinamide Forecast
  10.1.3 APAC Rufinamide Forecast
  10.1.4 Europe Rufinamide Forecast
  10.1.5 Middle East & Africa Rufinamide Forecast
10.2 Americas Rufinamide Forecast by Country (2026-2031)
  10.2.1 United States Market Rufinamide Forecast
  10.2.2 Canada Market Rufinamide Forecast
  10.2.3 Mexico Market Rufinamide Forecast
  10.2.4 Brazil Market Rufinamide Forecast
10.3 APAC Rufinamide Forecast by Region (2026-2031)
  10.3.1 China Rufinamide Market Forecast
  10.3.2 Japan Market Rufinamide Forecast
  10.3.3 Korea Market Rufinamide Forecast
  10.3.4 Southeast Asia Market Rufinamide Forecast
  10.3.5 India Market Rufinamide Forecast
  10.3.6 Australia Market Rufinamide Forecast
10.4 Europe Rufinamide Forecast by Country (2026-2031)
  10.4.1 Germany Market Rufinamide Forecast
  10.4.2 France Market Rufinamide Forecast
  10.4.3 UK Market Rufinamide Forecast
  10.4.4 Italy Market Rufinamide Forecast
  10.4.5 Russia Market Rufinamide Forecast
10.5 Middle East & Africa Rufinamide Forecast by Region (2026-2031)
  10.5.1 Egypt Market Rufinamide Forecast
  10.5.2 South Africa Market Rufinamide Forecast
  10.5.3 Israel Market Rufinamide Forecast
  10.5.4 Turkey Market Rufinamide Forecast
10.6 Global Rufinamide Forecast by Type (2026-2031)
10.7 Global Rufinamide Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Rufinamide Forecast

11 KEY PLAYERS ANALYSIS

11.1 Eisai
  11.1.1 Eisai Company Information
  11.1.2 Eisai Rufinamide Product Offered
  11.1.3 Eisai Rufinamide Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Eisai Main Business Overview
  11.1.5 Eisai Latest Developments
11.2 Glenmark Pharms
  11.2.1 Glenmark Pharms Company Information
  11.2.2 Glenmark Pharms Rufinamide Product Offered
  11.2.3 Glenmark Pharms Rufinamide Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Glenmark Pharms Main Business Overview
  11.2.5 Glenmark Pharms Latest Developments
11.3 Mylan
  11.3.1 Mylan Company Information
  11.3.2 Mylan Rufinamide Product Offered
  11.3.3 Mylan Rufinamide Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Mylan Main Business Overview
  11.3.5 Mylan Latest Developments
11.4 West-ward Pharms
  11.4.1 West-ward Pharms Company Information
  11.4.2 West-ward Pharms Rufinamide Product Offered
  11.4.3 West-ward Pharms Rufinamide Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 West-ward Pharms Main Business Overview
  11.4.5 West-ward Pharms Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rufinamide Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Rufinamide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Oral suspension
Table 5. Rufinamide Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Rufinamide Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Rufinamide Market Size Market Share by Type (2020-2025)
Table 8. Rufinamide Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Rufinamide Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Rufinamide Market Size Market Share by Application (2020-2025)
Table 11. Global Rufinamide Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Rufinamide Revenue Market Share by Player (2020-2025)
Table 13. Rufinamide Key Players Head office and Products Offered
Table 14. Rufinamide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Rufinamide Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Rufinamide Market Size Market Share by Region (2020-2025)
Table 19. Global Rufinamide Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Rufinamide Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Rufinamide Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Rufinamide Market Size Market Share by Country (2020-2025)
Table 23. Americas Rufinamide Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Rufinamide Market Size Market Share by Type (2020-2025)
Table 25. Americas Rufinamide Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Rufinamide Market Size Market Share by Application (2020-2025)
Table 27. APAC Rufinamide Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Rufinamide Market Size Market Share by Region (2020-2025)
Table 29. APAC Rufinamide Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Rufinamide Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Rufinamide Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Rufinamide Market Size Market Share by Country (2020-2025)
Table 33. Europe Rufinamide Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Rufinamide Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Rufinamide Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Rufinamide Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Rufinamide Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Rufinamide
Table 39. Key Market Challenges & Risks of Rufinamide
Table 40. Key Industry Trends of Rufinamide
Table 41. Global Rufinamide Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Rufinamide Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Rufinamide Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Rufinamide Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Eisai Details, Company Type, Rufinamide Area Served and Its Competitors
Table 46. Eisai Rufinamide Product Offered
Table 47. Eisai Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Eisai Main Business
Table 49. Eisai Latest Developments
Table 50. Glenmark Pharms Details, Company Type, Rufinamide Area Served and Its Competitors
Table 51. Glenmark Pharms Rufinamide Product Offered
Table 52. Glenmark Pharms Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Glenmark Pharms Main Business
Table 54. Glenmark Pharms Latest Developments
Table 55. Mylan Details, Company Type, Rufinamide Area Served and Its Competitors
Table 56. Mylan Rufinamide Product Offered
Table 57. Mylan Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Mylan Main Business
Table 59. Mylan Latest Developments
Table 60. West-ward Pharms Details, Company Type, Rufinamide Area Served and Its Competitors
Table 61. West-ward Pharms Rufinamide Product Offered
Table 62. West-ward Pharms Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. West-ward Pharms Main Business
Table 64. West-ward Pharms Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rufinamide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rufinamide Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Rufinamide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Rufinamide Sales Market Share by Country/Region (2024)
Figure 8. Rufinamide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Rufinamide Market Size Market Share by Type in 2024
Figure 10. Rufinamide in Adults
Figure 11. Global Rufinamide Market: Adults (2020-2025) & ($ millions)
Figure 12. Rufinamide in Pediatric patients
Figure 13. Global Rufinamide Market: Pediatric patients (2020-2025) & ($ millions)
Figure 14. Global Rufinamide Market Size Market Share by Application in 2024
Figure 15. Global Rufinamide Revenue Market Share by Player in 2024
Figure 16. Global Rufinamide Market Size Market Share by Region (2020-2025)
Figure 17. Americas Rufinamide Market Size 2020-2025 ($ millions)
Figure 18. APAC Rufinamide Market Size 2020-2025 ($ millions)
Figure 19. Europe Rufinamide Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Rufinamide Market Size 2020-2025 ($ millions)
Figure 21. Americas Rufinamide Value Market Share by Country in 2024
Figure 22. United States Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Rufinamide Market Size Market Share by Region in 2024
Figure 27. APAC Rufinamide Market Size Market Share by Type (2020-2025)
Figure 28. APAC Rufinamide Market Size Market Share by Application (2020-2025)
Figure 29. China Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 33. India Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Rufinamide Market Size Market Share by Country in 2024
Figure 36. Europe Rufinamide Market Size Market Share by Type (2020-2025)
Figure 37. Europe Rufinamide Market Size Market Share by Application (2020-2025)
Figure 38. Germany Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 39. France Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Rufinamide Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Rufinamide Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Rufinamide Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Rufinamide Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Rufinamide Market Size 2026-2031 ($ millions)
Figure 52. APAC Rufinamide Market Size 2026-2031 ($ millions)
Figure 53. Europe Rufinamide Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Rufinamide Market Size 2026-2031 ($ millions)
Figure 55. United States Rufinamide Market Size 2026-2031 ($ millions)
Figure 56. Canada Rufinamide Market Size 2026-2031 ($ millions)
Figure 57. Mexico Rufinamide Market Size 2026-2031 ($ millions)
Figure 58. Brazil Rufinamide Market Size 2026-2031 ($ millions)
Figure 59. China Rufinamide Market Size 2026-2031 ($ millions)
Figure 60. Japan Rufinamide Market Size 2026-2031 ($ millions)
Figure 61. Korea Rufinamide Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Rufinamide Market Size 2026-2031 ($ millions)
Figure 63. India Rufinamide Market Size 2026-2031 ($ millions)
Figure 64. Australia Rufinamide Market Size 2026-2031 ($ millions)
Figure 65. Germany Rufinamide Market Size 2026-2031 ($ millions)
Figure 66. France Rufinamide Market Size 2026-2031 ($ millions)
Figure 67. UK Rufinamide Market Size 2026-2031 ($ millions)
Figure 68. Italy Rufinamide Market Size 2026-2031 ($ millions)
Figure 69. Russia Rufinamide Market Size 2026-2031 ($ millions)
Figure 70. Egypt Rufinamide Market Size 2026-2031 ($ millions)
Figure 71. South Africa Rufinamide Market Size 2026-2031 ($ millions)
Figure 72. Israel Rufinamide Market Size 2026-2031 ($ millions)
Figure 73. Turkey Rufinamide Market Size 2026-2031 ($ millions)
Figure 74. Global Rufinamide Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Rufinamide Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Rufinamide Market Size 2026-2031 ($ millions)